KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Sales: 2010-2025

Historic Return on Sales for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Sep 2025 value amounting to 0.32%.

  • Regeneron Pharmaceuticals' Return on Sales fell 1.00% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.31% for FY2024, which is 1.00% up from last year.
  • Regeneron Pharmaceuticals' Return on Sales amounted to 0.32% in Q3 2025, which was up 2.44% from 0.31% recorded in Q2 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Sales ranged from a high of 0.73% in Q4 2022 and a low of 0.29% during Q1 2024.
  • Moreover, its 3-year median value for Return on Sales was 0.32% (2024), whereas its average is 0.35%.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Sales grew by 23bps in 2022, and later slumped by 43bps in 2023.
  • Quarterly analysis of 5 years shows Regeneron Pharmaceuticals' Return on Sales stood at 0.50% in 2021, then increased by 23bps to 0.73% in 2022, then crashed by 43bps to 0.30% in 2023, then climbed by 1bps to 0.31% in 2024, then decreased by 1bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 0.31% for Q2 2025, and 0.32% during Q1 2025.